Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/31326

Type
Article
Copyright
Restricted access
Embargo date
2030-01-01
Collections
Share

Statistics
Metadata
Show full item record

BEHAVIORAL IMPACT, ACCEPTABILITY, AND HIV INCIDENCE AMONG HOMOSEXUAL MEN WITH ACCESS TO POSTEXPOSURE CHEMOPROPHYLAXIS FOR HIV
Schechter, Mauro et al. | Date Issued: 2004
Author
Schechter, Mauro
do Lago, Regina F.
Mendelsohn, Aaron B.
Moreira, Ronaldo I.
Moulton, Lawrence H.
Harrison, Lee H.
Praca Onze Study Team
Affilliation
Hospital Universitário Clementino Fraga Filho. Serviço de Doenças Infecciosas./ Universidade Federal do Rio de Janeiro. Departamento de Medicina Preventiva. Rio de Janeiro, RJ, Brasil.
Hospital Universitário Clementino Fraga Filho. Serviço de Doenças Infecciosas./ Universidade Federal do Rio de Janeiro. Departamento de Medicina Preventiva. Rio de Janeiro, RJ, Brasil.
University of Pittsburgh. Graduate School of Public Health. Department of Epidemiology. Pittsburgh, PA, USA.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil./ Hospital Universitário Clementino Fraga Filho. Serviço de Doenças Infecciosas./ Universidade Federal do Rio de Janeiro. Departamento de Medicina Preventiva. Rio de Janeiro, RJ, Brasil.
Johns Hopkins University. Department of International Health and Department of Biostatistics. Baltimore, MD, USA.
University of Pittsburgh. Graduate School of Public Health and School of Medicine. Infectious Diseases Epidemiology Research Unit. Pittsburgh, PA, USA.
Abstract
Little is known about the behavioral impact, acceptability, and incidence of HIV infection in persons with easy access to post-sexual exposure prophylaxis (PEP) to prevent HIV.
Keywords
Postexposure chemoprophylaxis
Postexposure prophylaxis
HIV
HIV incidence
Lamivudine
Zidovudine
 
Publisher
Lippincott, Williams & Wilkins,
Citation
SCHECHTER, M. et al. Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. Journal of Acquired Immune Deficiency Syndromes, v. 35, n. 5, p. 519-525, 2004.
ISSN
1525-4135
Notes
Presentes no Praza Onze study team: Nilo Fernandes; Ruth Friedman (Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.)